Answer
Patients receiving ribociclib (Kisqali) should avoid breastfeeding for at least 21 days after the last dose.
Sources for this answer
- Kisqali film coated tabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 26Document updated
Sources checked